June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA
May 17, 2024, 11:18

Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA

Agenus shared on LinkedIn:

“Today we announced that Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA to discuss our botensilimab/balstilimab therapy for relapsed or refractory metastatic colorectal cancer.

Learn more.”

Source: Agenus/LinkedIn